This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cordon-Cardo, C. Search for Related Content PubMed PubMed Citation Articles by Cordon-Cardo, C.

American Journal of Pathology, Vol 147, 545-560, Copyright © 1995 by American Society for Investigative Pathology

REVIEWS

Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia

C Cordon-Cardo
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Neoplastic diseases are characterized by uncoordinated cell growth. Cellular proliferation follows an orderly progression through the cell cycle, which is governed by protein complexes composed of cyclins and cyclin-dependent kinases. These complexes exert their regulatory function by phosphorylation of key proteins involved in cell cycle transitions, such as the product encoded by the retinoblastoma gene (pRB). Mutations and overexpression of cyclins and cyclin-dependent kinases, mainly cyclin D1 and Cdk4, have been reported and proposed to be oncogenic events. More recently, a new family of negative regulators functioning as Cdk-inhibitory molecules has been identified. Because of their recessive nature in cell cycle control and the fact that some of them are mutated in human tumors, it has been suggested that they may also function as tumor suppressor genes. It appears that the molecular networking of these proteins and complexes impact on two fundamental cell cycle regulators: p53 and pRB. Cross-talk pathways between these two nuclear proteins are being delineated, implying potential links between p53 and pRB in cell cycle control, apoptosis, and tumor progression. In addition, the high rate and mutation pattern of TP53 and RB in primary tumors have rendered them prototype tumor suppressor genes. Furthermore, detection of TP53 and RB mutations and altered expression of their encoded products appear to be of clinical significance, often correlating with prognosis, when identified in specific cancers. Based on these findings, new strategies are being developed in the emerging field of gene replacement-therapy.

This article has been cited by other articles:

				M. Derenzini, G. Donati, G. Mazzini, L. Montanaro, M. Vici, C. Ceccarelli, D. Santini, M. Taffurelli, and D. Trere Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure Clin. Cancer Res., April 1, 2008; 14(7): 2199 - 2209. [Abstract] [Full Text] [PDF]

				B. Anthony, F. C. Zhou, T. Ogawa, C. R. Goodlett, and J. Ruiz Alcohol Exposure Alters Cell Cycle and Apoptotic Events During Early Neurulation Alcohol Alcohol., February 18, 2008; (2008) agm166v1. [Abstract] [Full Text] [PDF]

				B. Lubyova, M. J. Kellum, J. A. Frisancho, and P. M. Pitha Stimulation of c-Myc Transcriptional Activity by vIRF-3 of Kaposi Sarcoma-associated Herpesvirus J. Biol. Chem., November 2, 2007; 282(44): 31944 - 31953. [Abstract] [Full Text] [PDF]

				A. S. Hammer, B. Williams, H. H. Dietz, and S. J. Hamilton-Dutoit High-throughput Immunophenotyping of 43 Ferret Lymphomas Using Tissue Microarray Technology Vet. Pathol., March 1, 2007; 44(2): 196 - 203. [Abstract] [Full Text] [PDF]

				M. Urushibara, Y. Kageyama, T. Akashi, Y. Otsuka, T. Takizawa, M. Koike, and K. Kihara HSP60 may Predict Good Pathological Response to Neoadjuvant Chemoradiotherapy in Bladder Cancer Jpn. J. Clin. Oncol., January 1, 2007; 37(1): 56 - 61. [Abstract] [Full Text] [PDF]

				R. J. Hung, P. Boffetta, F. Canzian, N. Moullan, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, et al. Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe Cancer Res., August 15, 2006; 66(16): 8280 - 8286. [Abstract] [Full Text] [PDF]

				A. J. Berger, D. W. Davis, C. Tellez, V. G. Prieto, J. E. Gershenwald, M. M. Johnson, D. L. Rimm, and M. Bar-Eli Automated Quantitative Analysis of Activator Protein-2{alpha} Subcellular Expression in Melanoma Tissue Microarrays Correlates with Survival Prediction Cancer Res., December 1, 2005; 65(23): 11185 - 11192. [Abstract] [Full Text] [PDF]

				G. Li, Z. Liu, E. M. Sturgis, Q. Shi, R. M. Chamberlain, M. R. Spitz, and Q. Wei Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2005; 26(9): 1596 - 1602. [Abstract] [Full Text] [PDF]

				M. C. d. C. Miguel, M. C. Oliveira, F. R. G. Seabra, L. M. G. Queiroz, R. d. A. Freitas, and L. Batista de Souza {beta}-Catenin and Cyclin D1 in Mucoepidermoid Carcinoma of Variable Histologic Grades Arch Otolaryngol Head Neck Surg, August 1, 2005; 131(8): 701 - 706. [Abstract] [Full Text] [PDF]

				J. Dupont, B. Bienvenu, C. Aghajanian, S. Pezzulli, P. Sabbatini, P. Vongphrachanh, C. Chang, C. Perkell, K. Ng, S. Passe, et al. Phase I and Pharmacokinetic Study of the Novel Oral Cell-Cycle Inhibitor Ro 31-7453 in Patients With Advanced Solid Tumors J. Clin. Oncol., August 15, 2004; 22(16): 3366 - 3374. [Abstract] [Full Text] [PDF]

				M Derenzini, C Ceccarelli, D Santini, M Taffurelli, and D Trere The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status J. Clin. Pathol., July 1, 2004; 57(7): 755 - 761. [Abstract] [Full Text] [PDF]

				G. Li, E. M. Sturgis, L.-E. Wang, R. M. Chamberlain, M. R. Spitz, A. K. El-Naggar, W. K. Hong, and Q. Wei Association between the V109G Polymorphism of the p27 Gene and the Risk and Progression of Oral Squamous Cell Carcinoma Clin. Cancer Res., June 15, 2004; 10(12): 3996 - 4002. [Abstract] [Full Text] [PDF]

				B. Bedogni, M. S. O'Neill, S. M. Welford, D. M. Bouley, A. J. Giaccia, N. C. Denko, and M. B. Powell Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice Cancer Res., April 1, 2004; 64(7): 2552 - 2560. [Abstract] [Full Text] [PDF]

				C. Cordon-Cardo p53 and RB: Simple Interesting Correlates or Tumor Markers of Critical Predictive Nature? J. Clin. Oncol., March 15, 2004; 22(6): 975 - 977. [Full Text] [PDF]

				S. J. Chatterjee, R. Datar, D. Youssefzadeh, B. George, P. J. Goebell, J. P. Stein, L. Young, S.-R. Shi, C. Gee, S. Groshen, et al. Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma J. Clin. Oncol., March 15, 2004; 22(6): 1007 - 1013. [Abstract] [Full Text] [PDF]

				H P Kourea, A K Koutras, C D Scopa, M N Marangos, E Tzoracoeleftherakis, D Koukouras, and H P Kalofonos Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma Mol. Pathol., December 1, 2003; 56(6): 328 - 335. [Abstract] [Full Text] [PDF]

				A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder Mol. Pathol., December 1, 2003; 56(6): 353 - 361. [Abstract] [Full Text] [PDF]

				K. Kameyama, C.-l. Huang, D. Liu, D. Masuya, T. Nakashima, S. Sumitomo, Y. Takami, M. Kinoshita, and H. Yokomise Reduced ING1b Gene Expression Plays an Important Role in Carcinogenesis of Non-Small Cell Lung Cancer Patients Clin. Cancer Res., October 15, 2003; 9(13): 4926 - 4934. [Abstract] [Full Text] [PDF]

				X. Jia, C. Han, and J. Chen Effects of Tea on Preneoplastic Lesions and Cell Cycle Regulators in Rat Liver Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1663 - 1667. [Abstract] [Full Text] [PDF]

				A. Hoos, A. Nissan, A. Stojadinovic, J. Shia, C. V. Hedvat, D. H. Y. Leung, P. B. Paty, D. Klimstra, C. Cordon-Cardo, and W. D. Wong Tissue Microarray Molecular Profiling of Early, Node-negative Adenocarcinoma of the Rectum: A Comprehensive Analysis Clin. Cancer Res., December 1, 2002; 8(12): 3841 - 3849. [Abstract] [Full Text] [PDF]

				T. Tokugawa, H. Sugihara, T. Tani, and T. Hattori Modes of Silencing of p16 in Development of Esophageal Squamous Cell Carcinoma Cancer Res., September 1, 2002; 62(17): 4938 - 4944. [Abstract] [Full Text] [PDF]

				Z. Shen, X.-F. Wen, F. Lan, Z.-Z. Shen, and Z.-M. Shao The Tumor Suppressor Gene LKB1 Is Associated with Prognosis in Human Breast Carcinoma Clin. Cancer Res., July 1, 2002; 8(7): 2085 - 2090. [Abstract] [Full Text] [PDF]

				M. Volm, R. Koomagi, J. Mattern, and T. Efferth Expression Profile of Genes in Non-Small Cell Lung Carcinomas from Long-Term Surviving Patients Clin. Cancer Res., June 1, 2002; 8(6): 1843 - 1848. [Abstract] [Full Text] [PDF]

				S. Vanzulli, A. Efeyan, F. Benavides, L. A. Helguero, G. Peters, J. Shen, C. J. Conti, C. Lanari, and A. Molinolo p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas Carcinogenesis, May 1, 2002; 23(5): 749 - 758. [Abstract] [Full Text] [PDF]

				A. Hoos, A. Stojadinovic, B. Singh, M. E. Dudas, D. H. Y. Leung, A. R. Shaha, J. P. Shah, M. F. Brennan, C. Cordon-Cardo, and R. Ghossein Clinical Significance of Molecular Expression Profiles of Hurthle Cell Tumors of the Thyroid Gland Analyzed via Tissue Microarrays Am. J. Pathol., January 1, 2002; 160(1): 175 - 183. [Abstract] [Full Text] [PDF]

				Y. A. Elsayed and E. A. Sausville Selected Novel Anticancer Treatments Targeting Cell Signaling Proteins Oncologist, December 1, 2001; 6(6): 517 - 537. [Abstract] [Full Text] [PDF]

				S. J. Diaz-Cano, M. de Miguel, A. Blanes, R. Tashjian, and H. J. Wolfe Germline RET 634 Mutation Positive MEN 2A-related C-Cell Hyperplasias Have Genetic Features Consistent with Intraepithelial Neoplasia J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3948 - 3957. [Abstract] [Full Text] [PDF]

				A. Hoos, J. J. Lewis, C. R. Antonescu, M. E. Dudas, L. Leon, J. M. Woodruff, M. F. Brennan, and C. Cordon-Cardo Characterization of Molecular Abnormalities in Human Fibroblastic Neoplasms: A Model for Genotype-Phenotype Association in Soft Tissue Tumors Cancer Res., April 1, 2001; 61(7): 3171 - 2175. [Abstract] [Full Text]

				A. Hoos, M. J. Urist, A. Stojadinovic, S. Mastorides, M. E. Dudas, D. H. Y. Leung, D. Kuo, M. F. Brennan, J. J. Lewis, and C. Cordon-Cardo Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic Tumors Am. J. Pathol., April 1, 2001; 158(4): 1245 - 1251. [Abstract] [Full Text] [PDF]

				W. Li, J. Fan, and J. R. Bertino Selective Sensitization of Retinoblastoma Protein-deficient Sarcoma Cells to Doxorubicin by Flavopiridol-mediated Inhibition of Cyclin-dependent Kinase 2 Kinase Activity Cancer Res., March 1, 2001; 61(6): 2579 - 2582. [Abstract] [Full Text]

				J Georgieva, P Sinha, and D Schadendorf Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions J. Clin. Pathol., March 1, 2001; 54(3): 229 - 235. [Abstract] [Full Text] [PDF]

				G. Juan and C. Cordon-Cardo Intranuclear Compartmentalization of Cyclin E during the Cell Cycle: Disruption of the Nucleoplasm-Nucleolar Shuttling of Cyclin E in Bladder Cancer Cancer Res., February 1, 2001; 61(3): 1220 - 1226. [Abstract] [Full Text]

				A. R. Cachia, J. O. Indsto, K. M. McLaren, G. J. Mann, and M. J. Arends CDKN2A Mutation and Deletion Status in Thin and Thick Primary Melanoma Clin. Cancer Res., September 1, 2000; 6(9): 3511 - 3515. [Abstract] [Full Text]

				K. Bani-Hani, I. G. Martin, L. J. Hardie, N. Mapstone, J. A. Briggs, D. Forman, and C. P. Wild Prospective Study of Cyclin D1 Overexpression in Barrett's Esophagus: Association With Increased Risk of Adenocarcinoma J Natl Cancer Inst, August 16, 2000; 92(16): 1316 - 1321. [Abstract] [Full Text] [PDF]

				J. Sinclair, J. Baillie, L. Bryant, and R. Caswell Human cytomegalovirus mediates cell cycle progression through G1 into early S phase in terminally differentiated cells J. Gen. Virol., June 1, 2000; 81(6): 1553 - 1565. [Abstract] [Full Text]

				M. Drobnjak, I. Osman, H. I. Scher, M. Fazzari, and C. Cordon-Cardo Overexpression of Cyclin D1 Is Associated with Metastatic Prostate Cancer to Bone Clin. Cancer Res., May 1, 2000; 6(5): 1891 - 1895. [Abstract] [Full Text]

				L. Cheng, R. V. Lloyd, A. L. Weaver, T. M. Pisansky, J. C. Cheville, D. M. Ramnani, B. C. Leibovich, M. L. Blute, H. Zincke, and D. G. Bostwick The Cell Cycle Inhibitors p21WAF1 and p27KIP1 Are Associated with Survival in Patients Treated by Salvage Prostatectomy after Radiation Therapy Clin. Cancer Res., May 1, 2000; 6(5): 1896 - 1899. [Abstract] [Full Text]

				S. J. Shankland and G. Wolf Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis Am J Physiol Renal Physiol, April 1, 2000; 278(4): F515 - F529. [Abstract] [Full Text] [PDF]

				C. R. Antonescu, D. H. Leung, M. Dudas, M. Ladanyi, M. Brennan, J. M. Woodruff, and C. Cordon-Cardo Alterations of Cell Cycle Regulators in Localized Synovial Sarcoma : A Multifactorial Study with Prognostic Implications Am. J. Pathol., March 1, 2000; 156(3): 977 - 983. [Abstract] [Full Text] [PDF]

				P. E. Ginn, L. E. Fox, J. C. Brower, A. Gaskin, I. D. Kurzman, and P. S. Kubilis Immunohistochemical Detection of p53 Tumor-Suppressor Protein is a Poor Indicator of Prognosis for Canine Cutaneous Mast Cell Tumors Vet. Pathol., January 1, 2000; 37(1): 33 - 39. [Abstract] [Full Text] [PDF]

				S. J. Diaz-Cano, M. de Miguel, A. Blanes, R. Tashjian, H. Galera, and H. J. Wolfe Clonality as Expression of Distinctive Cell Kinetics Patterns in Nodular Hyperplasias and Adenomas of the Adrenal Cortex Am. J. Pathol., January 1, 2000; 156(1): 311 - 319. [Abstract] [Full Text] [PDF]

				G. P. Nielsen, A. O. Stemmer-Rachamimov, Y. Ino, M. B. Moller, A. E. Rosenberg, and D. N. Louis Malignant Transformation of Neurofibromas in Neurofibromatosis 1 Is Associated with CDKN2A/p16 Inactivation Am. J. Pathol., December 1, 1999; 155(6): 1879 - 1884. [Abstract] [Full Text] [PDF]

				H. P. Kourea, C. Cordon-Cardo, M. Dudas, D. Leung, and J. M. Woodruff Expression of p27kip and Other Cell Cycle Regulators in Malignant Peripheral Nerve Sheath Tumors and Neurofibromas : The Emerging Role of p27kip in MalignantTransformation of Neurofibromas Am. J. Pathol., December 1, 1999; 155(6): 1885 - 1891. [Abstract] [Full Text] [PDF]

				C. Pfister, L. Moore, P. Allard, H. Larue, L. Lacombe, B. Tetu, F. Meyer, and Y. Fradet Predictive Value of Cell Cycle Markers p53, MDM2, p21, and Ki-67 in Superficial Bladder Tumor Recurrence Clin. Cancer Res., December 1, 1999; 5(12): 4079 - 4084. [Abstract] [Full Text] [PDF]

				C. Cordon-Cardo and C. Prives At the Crossroads of Inflammation and Tumorigenesis J. Exp. Med., November 15, 1999; 190(10): 1367 - 1370. [Full Text] [PDF]

				J. J. Del Pizzo, A. Borkowski, S. C. Jacobs, and N. Kyprianou Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient Survival Am. J. Pathol., October 1, 1999; 155(4): 1129 - 1136. [Abstract] [Full Text] [PDF]

				L. L. Gleich, Y. Q. Li, X. Wang, P. J. Stambrook, and J. L. Gluckman Variable Genetic Alterations and Survival in Head and Neck Cancer Arch Otolaryngol Head Neck Surg, September 1, 1999; 125(9): 949 - 952. [Abstract] [Full Text] [PDF]

				C.-l. Huang, N. Kohno, H. Inufusa, K. Kodama, T. Taki, and M. Miyake Overexpression of bax Associated with Mutations in the Loop-Sheet-Helix Motif of p53 Am. J. Pathol., September 1, 1999; 155(3): 955 - 965. [Abstract] [Full Text] [PDF]

				A. S. Baur, P. Shaw, N. Burri, F. Delacretaz, F. T. Bosman, and P. Chaubert Frequent Methylation Silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas Blood, September 1, 1999; 94(5): 1773 - 1781. [Abstract] [Full Text] [PDF]

				R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]

				I. Osman, M. Drobnjak, M. Fazzari, J. Ferrara, H. I. Scher, and C. Cordon-Cardo Inactivation of the p53 Pathway in Prostate Cancer: Impact on Tumor Progression Clin. Cancer Res., August 1, 1999; 5(8): 2082 - 2088. [Abstract] [Full Text] [PDF]

				Z.-T. Zhang, J. Pak, E. Shapiro, T.-T. Sun, and X.-R. Wu Urothelium-specific Expression of an Oncogene in Transgenic Mice Induced the Formation of Carcinoma in Situ and Invasive Transitional Cell Carcinoma Cancer Res., July 1, 1999; 59(14): 3512 - 3517. [Abstract] [Full Text] [PDF]

				I. Orlow, H. LaRue, I. Osman, L. Lacombe, L. Moore, F. Rabbani, F. Meyer, Y. Fradet, and C. Cordon-Cardo Deletions of the INK4A Gene in Superficial Bladder Tumors : Association with Recurrence Am. J. Pathol., July 1, 1999; 155(1): 105 - 113. [Abstract] [Full Text] [PDF]

				F. Barbieri, M. Cagnoli, N. Ragni, G. Foglia, C. Bruzzo, F. Pedulla, and A. Alama Increased Cyclin D1 Expression Is Associated with Features of Malignancy and Disease Recurrence in Ovarian Tumors Clin. Cancer Res., July 1, 1999; 5(7): 1837 - 1842. [Abstract] [Full Text] [PDF]

				R. DONNELLAN and R. CHETTY Cyclin E in human cancers FASEB J, May 1, 1999; 13(8): 773 - 780. [Abstract] [Full Text]

				R. Gallo, A. Padurean, T. Jayaraman, S. Marx, M. Roque, S. Adelman, J. Chesebro, J. Fallon, V. Fuster, A. Marks, et al. Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle Circulation, April 27, 1999; 99(16): 2164 - 2170. [Abstract] [Full Text] [PDF]

				B. Driscoll, S. Buckley, L. Barsky, K. Weinberg, K. D. Anderson, and D. Warburton Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L679 - L687. [Abstract] [Full Text] [PDF]

				I. Orlow, M. Drobnjak, Z.-F. Zhang, J. Lewis, J. M. Woodruff, M. F. Brennan, and C. Cordon-Cardo Alterations of INK4A and INK4B Genes in Adult Soft Tissue Sarcomas: Effect on Survival J Natl Cancer Inst, January 6, 1999; 91(1): 73 - 79. [Abstract] [Full Text] [PDF]

				V. G. Gorgoulis, P. Zacharatos, A. Kotsinas, T. Liloglou, A. Kyroudi, M. Veslemes, A. Rassidakis, T. D. Halazonetis, J. K. Field, and C. Kittas Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas : Relationship with p53 and MDM2 Protein Expression Am. J. Pathol., December 1, 1998; 153(6): 1749 - 1765. [Abstract] [Full Text] [PDF]

				L. Chin, G. Merlino, and R. A. DePinho Malignant melanoma: modern black plague and genetic black box Genes & Dev., November 15, 1998; 12(22): 3467 - 3481. [Full Text]

				M Roland and R M Rudd Genetics and pulmonary medicine bullet  7: Somatic mutations in the development of lung cancer Thorax, November 1, 1998; 53(11): 979 - 983. [Full Text]

				A. K. Konstantinidis, R. Radhakrishnan, F. Gu, R. N. Rao, and W.-K. Yeh Purification, Characterization, and Kinetic Mechanism of Cyclin D1·CDK4, a Major Target for Cell Cycle Regulation J. Biol. Chem., October 9, 1998; 273(41): 26506 - 26515. [Abstract] [Full Text] [PDF]

				G. V. Thomas, K. Szigeti, M. Murphy, G. Draetta, M. Pagano, and M. Loda Down-Regulation of p27 Is Associated with Development of Colorectal Adenocarcinoma Metastases Am. J. Pathol., September 1, 1998; 153(3): 681 - 687. [Abstract] [Full Text] [PDF]